Revolution Medicines
RVMD
Last Price
52 Week Range
$29.17 - $124.49
Next Earnings Date
May 06 2026 (Estimate)
Next Earnings Date
May 06 2026 (Est.)
Last Price
Revolution Medicines SEC Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Revolution Medicines, Inc. | 10-K | February 25, 2026 | |
Revolution Medicines, Inc. | 8-K | February 25, 2026 | |
Revolution Medicines, Inc. | 10-Q | November 5, 2025 | |
Revolution Medicines, Inc. | 8-K | November 5, 2025 | |
Revolution Medicines, Inc. | 8-K | October 17, 2025 | |
Revolution Medicines, Inc. | 8-K | September 10, 2025 | |
Revolution Medicines, Inc. | 8-K | August 6, 2025 | |
Revolution Medicines, Inc. | 10-Q | August 6, 2025 | |
Revolution Medicines, Inc. | 8-K | June 27, 2025 | |
Revolution Medicines, Inc. | 8-K | June 24, 2025 | |
Revolution Medicines, Inc. | 8-K | June 18, 2025 | |
Revolution Medicines, Inc. | 10-Q | May 7, 2025 | |
Revolution Medicines, Inc. | 8-K | May 7, 2025 | |
Revolution Medicines, Inc. | DEF 14A | April 29, 2025 | |
Revolution Medicines, Inc. | DEFA14A | April 29, 2025 | |
Revolution Medicines, Inc. | ARS | April 29, 2025 | |
Revolution Medicines, Inc. | 8-K | February 26, 2025 | |
Revolution Medicines, Inc. | 10-K | February 26, 2025 | |
Revolution Medicines, Inc. | 8-K | December 5, 2024 | |
Revolution Medicines, Inc. | 8-K | December 2, 2024 | |
Revolution Medicines, Inc. | 8-K | November 6, 2024 | |
Revolution Medicines, Inc. | 10-Q | November 6, 2024 | |
Revolution Medicines, Inc. | 8-K | October 25, 2024 | |
Revolution Medicines, Inc. | 8-K | October 23, 2024 | |
Revolution Medicines, Inc. | 8-K | August 7, 2024 | |
Revolution Medicines, Inc. | 10-Q | August 7, 2024 | |
Revolution Medicines, Inc. | 8-K | July 15, 2024 | |
Revolution Medicines, Inc. | 8-K | June 24, 2024 | |
Revolution Medicines, Inc. | 8-K | May 8, 2024 | |
Revolution Medicines, Inc. | 10-Q | May 8, 2024 |
Load More...
Gainify
Features
Platform
Resources
Learn
Socials
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
© 2026 Gainify. All rights reserved.